SCHEMBL30853447

SCHEMBL30853447

Nc1ccc(O)cc1C(=O)C[C@@H](N)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.55
HIF1A Q16665 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
KMO O15229 3/20 0.45
SLC7A5 Q01650 2/20 0.45
KYNU Q16719 1/20 0.44
CYP3A4 P08684 2/20 0.43
ADORA3 P0DMS8 2/20 0.43
ALOX15 P16050 2/20 0.43
HTR2A P28223 2/20 0.43
KMT2A Q03164 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
HTR1A P08908 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
NFKB1 P19838 1/20 0.43
HTR2C P28335 1/20 0.43
SLC6A4 P31645 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL288000 1.00 KDM4E (0.55) KDM4EHIF1ATDP1KMOSLC7A5
SCHEMBL288161 1.00 KDM4E (0.55) KDM4EHIF1ATDP1KMOSLC7A5
SCHEMBL30853452 1.00 KDM4E (0.55) KDM4EHIF1ATDP1KMOSLC7A5
SCHEMBL30853450 1.00 KDM4E (0.55) KDM4EHIF1ATDP1KMOSLC7A5
SCHEMBL30852381 1.00 KDM4E (0.55) KDM4EHIF1ATDP1KMOSLC7A5
SCHEMBL17629412 1.00 KDM4E (0.55) KDM4EHIF1ATDP1KMOSLC7A5
SCHEMBL4414897 0.84 KMT2A (0.44) KDM4EHIF1ATDP1SLC7A5KYNU
SCHEMBL8397345 0.83 KMO (0.51) KDM4EHIF1ATDP1KMOCYP3A4
SCHEMBL3146454 0.83 KDM4E (0.57) KDM4EHIF1ATDP1KMOMAPT
SCHEMBL9065248 0.83 KEAP1 (0.57) KDM4EHIF1ATDP1KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572737-A1 METHODS OF USING A SMALL MOLECULE CHEMICAL COMPOUND TO REDUCE THE APPEARANCE OF RHYTIDS AND WRINKLES Birchbiomed Inc. (CA) 2025-06-25 EP claimed
CN-120019060-A Compounds and their use for filtering ultraviolet and/or high-energy visible light 索利奥美公司 2025-05-16 CN claimed
WO-2024055116-A1 METHODS OF USING A SMALL MOLECULE CHEMICAL COMPOUND TO REDUCE THE APPEARANCE OF RHYTIDS AND WRINKLES BIRCHBIOMED INC. (CA) 2024-03-21 WO claimed
US-12551459-B2 Combination of kynurenine and antigen presenting cells (APC) as therapeutics and methods for their use in immune modulation THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2026-02-17 US disclosed
EP-4572737-A1 METHODS OF USING A SMALL MOLECULE CHEMICAL COMPOUND TO REDUCE THE APPEARANCE OF RHYTIDS AND WRINKLES Birchbiomed Inc. (CA) 2025-06-25 EP disclosed
CN-120019060-A Compounds and their use for filtering ultraviolet and/or high-energy visible light 索利奥美公司 2025-05-16 CN disclosed
WO-2024055116-A1 METHODS OF USING A SMALL MOLECULE CHEMICAL COMPOUND TO REDUCE THE APPEARANCE OF RHYTIDS AND WRINKLES BIRCHBIOMED INC. (CA) 2024-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12551459-B2 Combination of kynurenine and antigen presenting cells (APC) as therapeutics and methods for their use in immune modulation AADAT, IDO1, IAPP KDM4E 1466/4885HIF1A 1602/4885TDP1 3336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.